Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Herrinton, L. J.
Right arrow Articles by Selby, J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herrinton, L. J.
Right arrow Articles by Selby, J. V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 142, No. 7: 692-698
Copyright © 1995 by The Johns Hopkins University School of Hygiene and Public Health

other

Transferrin Saturation and Risk of Cancer

Lisa J. Herrinton, Gary D. Friedman, David Baer and Joseph V. Selby

The authors examined the hypothesis that relatively high levels of transferrin saturation increase the risk of cancer. They studied a cohort of prepaid health plan members whose transferrin saturation levels were measured during the period 1969–1971 and who were followed for cancer through 1990. After the exclusion of 10 percent of the subjects who received treatment for one or more of six chronic conditions or who were pregnant when the measurement was made and persons who contributed less than 5 years of follow-up, the authors were left with 38,538 persons who were followed for an average period of 17.7 years. In women, a positive association was observed between transferrin saturation and risk of stomach carcinoma (≥34.5% compared with ≤20.3%: relative risk (RR) = 3.5, 95% confidence interval (Cl) 0.98–12). In men, transferrin saturation was inversely associated with risk of colon and rectal carcinoma (≥40.7% compared with ≤26.0%: colon, RR = 0.62, 95% Cl 0.35–1.1; rectum, RR = 0.30, 95% Cl 0.08–1.1) and with non-Hodgkin's lymphoma (32.1–40.6% compared with ≤26.0%: RR = 0.31, 95% Cl 0.11–0.88; no cases observed with transferrin saturation ≥40.7%). The authors did not find evidence that the risk of epithelial cancer (all sites combined) was related to transferrin saturation level or to iron deficiency (≤5%) or overload (≥60%). Arn J Epidemiol 1995; 142:692–8.

cohort studies;; iron;; neoplasms;; transferrin


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Nutr.Home page
S. Hercberg, C. Estaquio, S. Czernichow, L. Mennen, N. Noisette, S. Bertrais, J.-C. Renversez, S. Briancon, A. Favier, and P. Galan
Iron Status and Risk of Cancers in the SU.VI.MAX Cohort
J. Nutr., November 1, 2005; 135(11): 2664 - 2668.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
A. T. Chan, J. Ma, G. J. Tranah, E. L. Giovannucci, N. Rifai, D. J. Hunter, and C. S. Fuchs
Hemochromatosis Gene Mutations, Body Iron Stores, Dietary Iron, and Risk of Colorectal Adenoma in Women
J Natl Cancer Inst, June 15, 2005; 97(12): 917 - 926.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
K. A. McGlynn, L. C. Sakoda, Y. Hu, R. E. Schoen, R. S. Bresalier, M. Yeager, S. Chanock, R. B. Hayes, and K. H. Buetow
Hemochromatosis Gene Mutations and Distal Adenomatous Colorectal Polyps
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 158 - 163.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
N. J. Shaheen, L. M. Silverman, T. Keku, L. B. Lawrence, E. M. Rohlfs, C. F. Martin, J. Galanko, and R. S. Sandler
Association Between Hemochromatosis (HFE) Gene Mutation Carrier Status and the Risk of Colon Cancer
J Natl Cancer Inst, January 15, 2003; 95(2): 154 - 159.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. Tseng, E. R. Greenberg, R. S. Sandler, J. A. Baron, R. W. Haile, B. S. Blumberg, and K. A. McGlynn
Serum Ferritin Concentration and Recurrence of Colorectal Adenoma
Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 625 - 630.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.